Loratadine provides early symptom control in seasonal allergic rhinitis

Allergy and Asthma Proceedings

Volumn 29, Issue 6, 2008, Pages 654-658

  Kaiser, Harold B ^a   Gopalan, Gokul ^b   Chung, Weiyuan ^b  

^a Clinical Research Institute   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Efficacy; Fexofenadine; Loratadine; Nasal congestion; Ocular symptoms; Post hoc analysis; Seasonal allergic rhinitis; Second generation antihistamines; Total nasal symptom score; Total symptom score

Indexed keywords

FEXOFENADINE; LORATADINE; PLACEBO; ANTIALLERGIC AGENT; DRUG DERIVATIVE; TERFENADINE;

ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAY FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SYMPTOM; TOTAL SYMPTOM SCORE; UNSPECIFIED SIDE EFFECT; ADOLESCENT; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; CHILD; FEMALE; HUMANS; LORATADINE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; TERFENADINE; YOUNG ADULT;

EID: 61749093962     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3166     Document Type: Article

References (14)

1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy 63(suppl 86):8-160, 2008.
2. Blaiss MS. Pediatric allergic rhinitis: Physical and mental complications. Allergy Asthma Proc 29:1-6, 2008.
3. Blaiss MS. Allergic rhinoconjunctivitis: Burden of disease. Allergy Asthma Proc 28:393-397, 2007.
4. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 28:3-9, 2007.
5. Meltzer EO. Allergic rhinitis: Managing the pediatric spectrum. Allergy Asthma Proc 27:2-8, 2006.
6. Rosenwasser L. New insights into the pathophysiology of allergic rhinitis. Allergy Asthma Proc 28:10-15, 2007.
7. Broide DH. The pathophysiology of allergic rhinitis. Allergy Asthma Proc 28:398-403, 2007.
8. Kaiser HB, Rooklin A, Spangler D, et al. Efficacy of loratadine compared with fexofenadine or placebo for the treatment of seasonal allergic rhinitis. Clin Drug Invest 21:571-578, 2001.
9. van Steekelenburg J, Clement PAR, and Beel MHL. Comparison of five new antihistamines in patients with allergic rhinitis using nasal provocation studies and skin tests. Allergy 57:346-350, 2002.
10. Crawford WW, Klaustermeyer WB, Lee PH, et al. Comparative efficacy of terfenadine, loratadine, and astemizole in perennial allergic rhinitis. Otolaryngol Head Neck Surg 118:668-673, 1998.
11. van Cauwenberge P, Juniper EF, and the STAR Investigating Group. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg, and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 30:891-899, 2000.
12. Prenner BM, Capano D, and Harris AG. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: A double blind comparison with crossover treatment of nonresponders. Clin Ther 22:760-769, 2000.
13. Casale TB, Andrade C, and Qu R. Safety and efficacy of oncedaily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. Allergy Asthma Proc 20:193-198, 1999.
14. Attitudes About Allergies. Rochester, NY: Harris Interactive, 2008. Available online at www.attitudesaboutallergies.com/pdf; last accessed May 5, 2008.